Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Abeona Therapeutics (GB:0H7R)
LSE:0H7R
RESEARCH TOOLSreports
Abeona Therapeutics (0H7R) Share Price & Analysis
0 Followers
0H7R Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.90 - $8.80
Previous Close$7.48
Volume364.00
Average Volume (3M)1.11K
Market Cap
$208.99M
Enterprise Value$166.75M
Total Cash (Recent Filing)$52.23M
Total Debt (Recent Filing)$9.98M
Price to Earnings (P/E)-2.9
Beta-0.80
Next Earnings
May 10, 2024EPS Estimate
-$0.57Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.59
Shares Outstanding27,355,037
10 Day Avg. Volume68
30 Day Avg. Volume1,114
Standard Deviation0.24
R-Squared0.16
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)13.93
Price to Sales (P/S)39.52
Price to Cash Flow (P/CF)-5.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue47.64
Enterprise Value/Gross Profit47.64
Enterprise Value/Ebitda-5.81
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Abeona Therapeutics News
Options Prices
Currently, No data available
---
Ownership Overview
51.29% Insiders
4.79% Mutual Funds
4.25% Other Institutional Investors
39.67% Public Companies and
Individual Investors
0H7R FAQ
What was Abeona Therapeutics’s price range in the past 12 months?
Abeona Therapeutics lowest share price was $2.90 and its highest was $8.80 in the past 12 months.
What is Abeona Therapeutics’s market cap?
Currently, no data Available
When is Abeona Therapeutics’s upcoming earnings report date?
Abeona Therapeutics’s upcoming earnings report date is May 10, 2024 which is in 24 days.
How were Abeona Therapeutics’s earnings last quarter?
Abeona Therapeutics released its earnings results on Mar 18, 2024. The company reported -$0.59 earnings per share for the quarter, missing the consensus estimate of -$0.47 by -$0.12.
Is Abeona Therapeutics overvalued?
According to Wall Street analysts Abeona Therapeutics’s price is currently Overvalued.
Does Abeona Therapeutics pay dividends?
Abeona Therapeutics does not currently pay dividends.
What is Abeona Therapeutics’s EPS estimate?
Abeona Therapeutics’s EPS estimate is -$0.57.
How many shares outstanding does Abeona Therapeutics have?
Abeona Therapeutics has 27,355,038 shares outstanding.
What happened to Abeona Therapeutics’s price movement after its last earnings report?
Abeona Therapeutics reported an EPS of -$0.59 in its last earnings report, missing expectations of -$0.47. Following the earnings report the stock price went down -18.992%.
Which hedge fund is a major shareholder of Abeona Therapeutics?
Among the largest hedge funds holding Abeona Therapeutics’s share is Western Standard Llc. It holds Abeona Therapeutics’s shares valued at 4M.
---
Abeona Therapeutics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
173.83%
12-Months-Change
Fundamentals
Return on Equity
-260.60%
Trailing 12-Months
Asset Growth
-0.33%
Trailing 12-Months
Company Description
Abeona Therapeutics
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.
---
0H7R Earnings Call
Q4 2024
0:00 / 0:00
---
0H7R Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering 0H7R
1 Year
1 Year Success Rate
2/4 ratings generated profit
1 Year Average Return
+0.75%
reiterated a buy rating 9 months ago
Copying Kristen Kluska's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +0.75% per trade.
---